These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30102820)

  • 1. Kidney transplant recipients with polycystic kidney disease have a lower risk of post-transplant BK infection than those with end-stage renal disease due to other causes.
    Plafkin C; Singh T; Astor BC; Parajuli S; Bhutani G; Safdar N; Panzer SE
    Transpl Infect Dis; 2018 Dec; 20(6):e12974. PubMed ID: 30102820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyomavirus BK replication in adult polycystic kidney disease post-renal transplant patients and possible role of cellular permissivity.
    Mitterhofer AP; Tinti F; Pietropaolo V; Barile M; Chiarini F; Meçule A; Ferretti G; Poli L; Berloco PB; Taliani G
    Transplant Proc; 2011 May; 43(4):1048-51. PubMed ID: 21620050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BK virus replication in renal transplant recipients: Analysis of potential risk factors may contribute in reactivation.
    Shenagari M; Monfared A; Eghtedari H; Pourkazemi A; Hasandokht T; Khosravi M; Asharfkhani B
    J Clin Virol; 2017 Nov; 96():7-11. PubMed ID: 28915452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of BK polyomavirus infection and association with renal dysfunction in pediatric heart transplant recipients.
    Ducharme-Smith A; Katz BZ; Bobrowski AE; Backer CL; Rychlik K; Pahl E
    J Heart Lung Transplant; 2015 Feb; 34(2):222-6. PubMed ID: 25540880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective monitoring of BK virus replication in renal transplant recipients.
    Koukoulaki M; Grispou E; Pistolas D; Balaska K; Apostolou T; Anagnostopoulou M; Tseleni-Kotsovili A; Hadjiconstantinou V; Paniara O; Saroglou G; Legakis N; Drakopoulos S
    Transpl Infect Dis; 2009 Feb; 11(1):1-10. PubMed ID: 18811631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
    Ji J; Feng S; Jiang Y; Wang W; Zhang X
    Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.
    van Doesum WB; Gard L; Bemelman FJ; de Fijter JW; Homan van der Heide JJ; Niesters HG; van Son WJ; Stegeman CA; Groen H; Riezebos-Brilman A; Sanders JSF
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28258601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of BK Virus in Renal Transplant at a Single Center: Experience With Our Ureteral Reimplantation Surgical Technique.
    Martínez Moreno AI; Guimerà Garcia J; Riera Mari V; Pieras Ayala E
    Exp Clin Transplant; 2020 Aug; 18(4):458-462. PubMed ID: 32490761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cause of End-Stage Renal Disease Is Not a Risk Factor for Cytomegalovirus Infection After Kidney Transplant.
    Singh T; Peery S; Astor BC; Parajuli S; Djamali A; Panzer SE
    Transplant Proc; 2019; 51(6):1810-1815. PubMed ID: 31256873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated heart and liver transplant recipients are at low risk for polyomavirus BKV nephropathy.
    Puliyanda DP; Amet N; Dhawan A; Hilo L; Radha RK; Bunnapradist S; Czer L; Martin P; Jordan S; Toyoda M
    Clin Transplant; 2006; 20(3):289-94. PubMed ID: 16824143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
    Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
    Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of BK virus infection in end-stage renal disease patients waiting for kidney transplantation--viral replication dynamics from pre- to post-transplant.
    Mitterhofer AP; Tinti F; Pietropaolo V; Umbro I; Anzivino E; Bellizzi A; Zavatto A; Poli L; Berloco PB; Taliani G
    Clin Transplant; 2014 Mar; 28(3):299-306. PubMed ID: 24506672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-transplant shedding of BK virus in urine is unrelated to post-transplant viruria and viremia in kidney transplant recipients.
    Bicalho CS; Oliveira RR; Pierrotti LC; Fink MC; Urbano PR; Nali LH; Luna EJ; Romano CM; David DR; David-Neto E; Pannuti CS
    Clin Transplant; 2016 Jul; 30(7):796-801. PubMed ID: 27101526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
    Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyoma BK virus reactivation in kidney and pancreas-kidney recipients.
    Matłosz B; Durlik M; Wesołowska A; Mróz A; Zegarska J; Rowiński W; Szmidt J
    Transplant Proc; 2005 Mar; 37(2):947-8. PubMed ID: 15848584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
    Gabardi S; Townsend K; Martin ST; Chandraker A
    Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.